• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 17
  • 8
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
11

Prevalência e estudo neuropsicológico de transtornos cognitivos e demências decorrentes de neuroinfecções em hospital de referência / Prevalence and neuropsychological study of disorders cognitive and dementia resulting from neuroinfecções in referral hospital

REIMER, Cláudio Henrique Ribeiro 27 March 2010 (has links)
Made available in DSpace on 2014-07-29T15:30:44Z (GMT). No. of bitstreams: 1 dissertacao claudio reimer.pdf: 403358 bytes, checksum: 6856ad112bf28d5c2777648d2a95f6af (MD5) Previous issue date: 2010-03-27 / Several infectious and parasitic diseases have been described as possible causes of cognitive loss, especially the neuroinfections that the location in the CNS, may evolve into frank dementia table (although subject to reversal). The vast possibilities as a result has large etiological heterogeneity of neuropsychiatric symptoms, which may hinder the clinical evaluation, but if using neuropsychological testing, it increases the chances of detection of cognitive and behavioral symptoms and therefore the diagnostic accuracy. The objective of the study is to estimate the prevalence of dementia and cognitive changes in neuroinfections, and characterize the co-morbid psychiatric symptoms. The sample comprised 60 patients with infection of the CNS in order to identify possible changes in performance in Mini-Mental State Examination (MMSE) and a questionnaire on activities of daily living for Pfeffer, and conduct behavioral assessment by questionnaire BEHAV - AD. By applying the MMSE and the Pfeffer questionnaire found that 20 patients (33.3% of the sample) had cognitive disorders without dementia and 23 patients were diagnosed as dementia, which is the framework neuropsychological most prevalent (38.3% of patients). If we include patients with cognitive disorders without dementia and those with dementia in one group, we obtain a total of 71.7% of the sample studied. In the psychiatric aspect, are part of apathy in 30% of cases and irritability in 43.4% of patients. Through this study, high prevalence of cognitive disorders (including dementia) between the tables of neuroinfecções, and psychiatric symptoms associated with rich, demonstrating the need for investigation of cognitive and behavioral aspects in patients with infections of the CNS. / Várias doenças infecciosas e parasitárias foram descritas como possíveis causadoras de prejuízos cognitivos, destacando-se as neuroinfecções que, pela localização no SNC, podem evolver para quadros demenciais francos (embora passíveis de reversão). As vastas possibilidades etiológicas tem como resultado grande heterogeneidade de sintomas neuropsiquiátricos, o que pode dificultar a avaliação clínica, mas se utilizarmos recursos de testagem neuropsicológica, aumentam-se as chances de detecção de sintomas cognitivos e comportamentais e consequentemente a precisão diagnóstica. O objetivo do estudo é estimar a prevalência de alterações cognitivas e demências nas neuroinfecções, além de caracterizar os sintomas psiquiátricos co-mórbidos. A amostra foi composta por 60 pacientes portadores de infecção do SNC no intuito de identificar possíveis alterações do desempenho no Mini-Exame do Estado Mental (MEEM) e questionário de atividades da vida diária de Pfeffer, além de realizar avaliação comportamental através do questionário BEHAVE-AD. Através da aplicação do MEEM e questionário de Pfeffer verificamos que 20 pacientes (33,3% da amostra) apresentaram transtornos cognitivos sem demência e 23 pacientes foram diagnosticados como demenciados, sendo este o quadro neuropsicológico mais prevalente (38,3% dos pacientes). Se incluirmos os pacientes com transtornos cognitivos sem demência e aqueles com demência em um só grupo, vamos obter um total de 71,7% da amostra estudada. No aspecto psiquiátrico, encontramos quadro de apatia em 30% dos casos e irritabilidade em 43,4% do total de pacientes. Através deste estudo, observamos alta prevalência de transtornos cognitivos (incluindo demências) entre os quadros de neuroinfecções, além de rica sintomatologia psiquiátrica associada, demonstrando a necessidade de investigação de aspectos cognitivos e comportamentais nos pacientes portadores de infecções do SNC.
12

Apport d'outils biologiques pour la caractérisation de tauopathies en regard de diverses présentations cliniques de pathologies neurodégénératives / Biological tools contribution for characterising several tauopathies with regard to various clinical presentations of neurodegenerative disorders

Seguin, Jérémie 05 April 2011 (has links)
Le diagnostic de la maladie d’Alzheimer (MA) est tardif et présente un manque de fiabilité en regard de l’examen neuropathologique postmortem permettant de confirmer ce diagnostic. En effet, les présentations cliniques de la MA peuvent être multiples et parfois atypiques. Des anomalies dans les concentrations des protéines tau, tau phosphorylées et amyloïdes bêta, au sein du liquide céphalorachidien (LCR), ont permis d’améliorer le diagnostic du vivant du patient. Nous avons évalué la performance de ces marqueurs, dans le LCR, utilisés pour le diagnostic de la MA dans les formes syndromiques atypiques. L’utilisation de ces marqueurs augmente la précision du diagnostic lors de ces différentes présentations cliniques. De plus, nous avons mis au point un test diagnostic biochimique postmortem des différentes tauopathies permettant de mieux les caractériser en complément de l’examen neuropathologique. Enfin, nous avons conçu et caractérisé des anticorps spécifiquement dirigés contre la protéine tau phosphorylée en position 231. Cet outil nous a permis de développer un test ELISA dans le LCR. Des résultats préliminaires suggéreraient une interaction in vivo entre les protéines tau et Prion. Ces résultats, décrits pour la première fois, sont corrélés à nos observations histologiques / Diagnosis of Alzheimer’s disease (AD) is late with a lack of reliability with regard to postmortem neuropathological examination that permits to confirm this diagnosis. Indeed, many clinical presentations of AD can occur and sometimes atypical. Anomalies in cerebrospinal fluid (CSF) levels of tau, phosphorylated tau and amyloid beta proteins permitted to improve antemortem diagnosis. We evaluated biomarkers performance, into CSF, used for AD diagnosis in syndromal atypical forms. The use of these biomarkers increases the accuracy of diagnosis during these different clinical presentations. Moreover, we adjusted a biochemical postmortem diagnosis test of tauopathies giving the interest to better characterize them in addition to neuropathological examination. Finally, we developed and characterized antibodies specifically directed against phosphorylated tau protein on 231 epitope. This tool permitted to make an ELISA test in CSF. Preliminary results may suggest an in vivo interation between tau and Prion proteins. These results, described for the first time, correlated with our histological observations
13

Pathological implications of the interaction between neurexins and alpha-synuclein in synucleinopathies

Fallon, Aurélie 11 1900 (has links)
La maladie de Parkinson (PD) et la démence à corps de Lewy (DLB) sont les deuxième et troisième maladies neurodégénératives les plus communes et font partie d’une classe de maladies appelées synucléinopathies. Les synucléinopathies sont associées à une pathologie liée à l’α-synucléine (α-syn) laquelle se caractérise par une accumulation de cette protéine dans les neurones, formant ainsi les corps de Lewy. L’α-syn pathologique se retrouve aussi sous forme d’oligomères et de fibrilles, qui sont toxiques pour les neurones et leurs synapses. L’une des premières anomalies observables chez les patients atteints de synucléinopathies est la dysfonction synaptique, souvent combinée à une perte de synapses. Il a été rapporté que les oligomères d’α-syn retrouvés au niveau des synapses précèdent la formation de corps de Lewy dans les neurones et leur transmission semble être associée à la progression des symptômes. Pourtant, les mécanismes moléculaires sous-jacents la dysfonction synaptique causée par l’α-syn restent inconnus. D’autre part, le fonctionnement normal des synapses est fortement régulé par une famille de protéines appelées organisateurs synaptiques. Les organisateurs synaptiques, incluant la protéine neurexine, sont des molécules d’adhésion cellulaire qui régulent la synaptogenèse, la plasticité, la libération des neurotransmetteurs et les fonctions cognitives. De plus, nous avons préliminairement montré que l’α-syn interagit avec l’isoforme β des neurexines (NRXs) (β-NRXs). Mon projet avait donc pour but de caractériser l’interaction α-syn/β-NRX et d’évaluer comment celle-ci contribue à la pathologie liée à l’α-syn. Nous avons émis l’hypothèse que cette interaction affecte la fonction synaptogénique liée aux NRXs et son trafic. Dans un premier temps, pour tester notre hypothèse, l’interaction α-syn/β-NRX a été évaluée grâce à des analyses de liaison à la surface cellulaire. Il a été constaté que les oligomères d’α-syn se lient fortement à NRX1,2β de manière dépendante du domaine riche en histidine (HRD), caractéristique de l’isoforme β, et cela sans perturber sa liaison à ses ligands endogènes postsynaptiques, neuroligine 1 (NLG1) et « leucine rich repeat transmembrane neuronal 2 » (LRRTM2). De plus, à travers des essais d’internalisation, nous avons observé que les oligomères d’α-syn altèrent le trafic de NRX1β en augmentant son internalisation de façon dépendante au HRD et altèrent également la différenciation NRX-dépendante de la synapse en synapse inhibitrice. Par conséquent, nous suggérons que cette internalisation accrue pourrait affecter la fonction synaptogénique associée aux NRXs. Ce travail contribue à une meilleure compréhension sur la façon dont l’α-syn provoque un dysfonctionnement synaptique, fournissant de nouvelles perspectives moléculaires et pharmacologiques sur les synucléinopathies. / Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) are the second and the third most common neurodegenerative disorders and are part of a class of diseases called synucleinopathies. Synucleinopathies are associated with an α-synuclein (α-syn) pathology which shows an accumulation of α-syn in neurons, forming Lewy bodies. This pathological α-syn can form oligomers and fibrils, which are toxic for neurons and their synapses. One of the first changes to occur in patients’ brain with synucleinopathies is synaptic dysfunction often combined with synapse loss. Synaptic α-syn oligomers were revealed to precede the formation of Lewy bodies, and their transmission to other neurons to correlate with the progression of the symptoms. Yet, the molecular mechanisms underlying how α-syn leads to synaptic dysfunction are unknown. Synaptic function is highly regulated by a protein family called synaptic organizers. Synaptic organizers are cell adhesion molecules that regulate synaptogenesis, plasticity, neurotransmitter release, synaptic plasticity and cognitive functions. Of this family, we have found that α-syn interacts with the β-isoforms of the neurexins (NRXs) family members (β-NRXs). My project aimed to characterize α-syn/β-NRX interaction and to evaluate how this interaction contributes to α-syn pathology. We hypothesized that this interaction affects NRX trafficking and its synaptic function. Firstly, to test our hypothesis, the α-syn/β-NRX interaction was characterized by performing cell surface binding assays. I found that α-syn oligomers strongly bind to NRX1,2β in a histidine rich domain (HRD)-dependent manner, without disrupting NRX binding to its postsynaptic binding partners, neuroligin 1 (NLG1) and leucine rich repeat transmembrane neuronal 2 (LRRTM2). Moreover, using internalization assays, we discovered that α-syn oligomers impair NRX trafficking by increasing NRX1β internalization in an HRD-dependent manner and impair NRX-dependent inhibitory presynaptic differentiation. Thereby, we suggest that this increased internalization affects the inhibitory synaptogenic function of NRX-based synaptic organizing complexes. This work contributes to a better understanding of how α-syn causes synaptic dysfunction, providing promising new molecular mechanisms and pharmacological insights into synucleinopathies.
14

Service coordination for system navigation when living with a neurological condition in Manitoba

Wetzel, Monika Y. 08 September 2015 (has links)
The purpose of this thesis is to explore the diverse experiences of accessing health and social services when living with a neurological condition in Manitoba. Using a qualitative research design, I conducted 15 in-depth semi-structured interviews with adults living with a neurological condition in Manitoba. Findings demonstrated how characteristics of patients, and their service providers/systems, either predisposed them to a lack of service coordination or enabled them to successfully navigate health and social services. In the event that those factors contributed to a need or desire for coordination, participants employed strategies to improve their experience accessing services by i. pursuing knowledge to improve access, ii. actively engaging in behaviours to improve services, or iii. mentally coping with inadequate services. To conclude, practical recommendations on possible initiatives to improve the daily experiences of individuals living with neurological conditions are also provided. / October 2015
15

Die Qualität der stationären Versorgung von Menschen mit Demenz- eine Analyse auf Grundlage der VIPP- Datenbank / The Quality of Inpatient Treatment of People with Dementia - An Analysis based on a German Indicator Project in Psychiatric Hospitals (VIPP project)

Chehadeh, Ramadan 27 September 2018 (has links)
No description available.
16

L’accompagnement infirmier des proches dans un processus décisionnel concernant la fin de vie d’une personne âgée vivant avec un trouble neurocognitif en centre d’hébergement

Daneau, Stéphanie 08 1900 (has links)
Les proches qui accompagnent une personne âgée vivant avec un trouble neurocognitif majeur à un stade avancé (TNC) en centre d’hébergement et de soins de longue durée (nommé CHSLD au Québec) rencontrent de multiples défis au quotidien. Parmi ceux-ci se retrouve la responsabilité qui leur est conférée de prendre les décisions relatives aux soins de santé pour la personne vivant avec un TNC lorsque celle-ci devient incapable de le faire. Certaines de ces décisions placent les proches dans un processus complexe qui doit être accompagné par l’équipe soignante, notamment lorsque les décisions en question auront potentiellement une incidence sur la fin de vie de la personne âgée. Les infirmières et infirmiers, par leurs compétences relatives aux soins à la famille et leur présence quotidienne directe auprès des résidentes et résidents et de leurs proches, se retrouvent dans une position privilégiée pour offrir cet accompagnement. Toutefois, peu d’études se sont intéressées aux différentes composantes de cet accompagnement. Par conséquent, cette étude visait à proposer une théorie de l’accompagnement infirmier des proches qui doivent prendre des décisions concernant la fin de vie d’une personne âgée vivant avec un TNC en CHSLD. Inspirée par la philosophie herméneutique de Gadamer (1960/2018) et la théorie du human caring élaborée par Watson (2012), une théorisation ancrée constructiviste a été réalisée auprès de neuf infirmières ou infirmiers et 10 proches rencontrés dans le cadre d’une entrevue semi-structurée individuelle. Les infirmiers et infirmières occupaient toutes un poste régulier en CHSLD depuis au moins un an, alors que les proches étaient ou avaient été impliqués dans le processus de prise de décisions concernant la fin de vie d’une personne âgée vivant avec un TNC en CHSLD. L’analyse des données s’est appuyée sur les principes suggérés par Charmaz (2014), qui incluent entre autres la codification initiale, la codification ciblée, la comparaison constante et l’écriture de mémos. Il découle de la théorie proposée l’aspect fondamental du lien de confiance établi entre l’infirmière ou l’infirmier et les proches, celui-ci ayant un impact important sur le processus de prise de décisions vécu par les proches et la qualité de l’accompagnement offert par l’infirmière ou l’infirmier. Ensuite, l’exploration du refus des soins palliatifs et le soutien du besoin des proches d’être témoin de l’état de santé actuel de la personne âgée vivant avec un TNC se sont aussi avérés des composantes essentielles de l’accompagnement infirmier. Finalement, l’enseignement au moment opportun ainsi qu’une transmission claire de l’information complètent les thèmes centraux de la théorie. Ces connaissances permettent de mieux comprendre les principaux éléments d’un accompagnement infirmier de qualité, contribuant ainsi à soutenir la pratique infirmière basée sur des résultats probants et à guider la recherche dans le développement d’interventions efficaces afin de faciliter l’expérience des proches. En outre, ces résultats démontrent l’apport indispensable des infirmières et infirmiers au processus de prise de décisions des proches. / Relatives supporting an older person living with an advanced major neurocognitive disorder (NCD) in a long-term care home (called a CHSLD in Quebec) encounter multiple challenges every day. Among them is the responsibility of making healthcare decisions on behalf of a relative living with an NCD, who is no longer able to do so themself. Some of these decisions launch relatives into a complex process that requires guidance from the healthcare team, especially when the decisions may impact the end-of-life of the person living with an NCD. Through their skills in family care and their daily presence directly among residents and relatives, nurses have a privileged role to play in offering this support. However, few studies have examined its various components. The aim of this study is therefore to propose a theory on nurses’ support of relatives making end-of-life decisions for a resident living with an NCD in a CHSLD. Inspired by Gadamer’s hermeneutical philosophy (1960/2018) and Watson’s theory of human caring (2012), a constructivist grounded theory was conducted with nine nurses and 10 relatives, whom were met in individual semi-structured interviews. These nurses had all held regular positions in CHSLDs for at least one year, while relatives were or had been involved in the end-of-life decision-making process for a person living with an NCD in a CHSLD. The data analysis was based on principles suggested by Charmaz (2014), including initial coding, focus coding, constant comparison, and the writing of memos. The proposed theory highlights trust as the fundamental aspect in the nurse-relative relationship. Indeed, trust has a significant impact on families’ decision-making process and on the quality of the support nurses provide to relatives. Exploring the refusal of palliative care and supporting relatives’ need to witness and take stock of the state of health of the person living with an NCD for themselves are two other essential components of nursing care. Finally, nurses’ well-timed education of relatives and clear transmission of information are other themes that are central to this theory. Deepening the understanding of the main elements of quality nursing support, this study reinforces evidence-based nursing practice and guides research leading to effective interventions that will ultimately facilitate relatives’ experience. Our results also demonstrate nurses’ invaluable contribution to relatives’ decision-making process.
17

Biological Age and Risk of Developing Alzheimer's Disease and Related Dementias

Gustavsson, Karolina January 2024 (has links)
Biologisk ålder (BA) har nyligen fått ökad uppmärksamhet att fördjupa förståelsen kring åldersrelaterade sjukdomar och dess behandlingar, eftersom åldersrelaterade förändringar utgör en grundläggande gemensam nämnare för dessa tillstånd. Medan kronologisk ålder (CA) mäts i år, kan biologisk ålder (BA) mätas på många olika sätt. I det här mastersarbetet användes blodbaserade biomarkörer som korrelerar med CA för att skapa uppskattningar av BA, med algoritmerna ‘PhenoAge’, ‘Klemera-Doubal metoden’ och ‘Homeostatic Dysregulation’. Biomarkörerna valdes ut genom Pearson och Spearmankorrelation med CA separat för varje kön. Dessutom validerades biomarkörerna mot mortalitet. Kohorten AMORIS (Apolipoprotein-relaterad dödlighetsrisk) användes för att beräkna tre olika biologiska åldersmått med hjälp av BioAge-paketet. För att undvika kollinearitet användes residualerna från dessa biologiska åldersmått, som representerar avvikelsen av BA från CA. PhenoAge-residualerna valdes för vidare undersökning på grund av deras robusthet. Sambandet mellan BA-residualer, särskilt PhenoAge-residualer, och Alzheimers sjukdom och relaterade demenssjukdomar (ADRD) utvärderades med Cox proportionella hazardmodeller. Justeringar gjordes för kön, utbildningsnivå och socioekonomisk status. Stratifiering för två åldersgrupper, över 65 och under 65, samt kön utfördes för två olika modeller. Modellens överensstämmelse varierade, över lag var den bättre för vaskulär demens och sämre för Alzheimers sjukdom. En ökad riskkvot hittades särskilt för vaskulär demens (PhenoAge HR=1.086, 95% CI=1.074 to 1.099), och till viss grad även för andra demenstyper men inte för Alzheimers sjukdom. Stratifiering efter ålder och kön visade varierande hazardkvoter, vilket tyder på olika riskprofiler bland olika demografiska grupper. En ökad risk för vaskulär demens noterades särskilt i åldersgruppen under 65 och bland män. Dessa differentierade risker belyser vikten av BA-markörer för att identifiera ökad risk för demensundergrupper och bekräftar värdet av att inkludera BA i bedömningen av ADRD för användning inom precisionsmedicin. / Biological age (BA) has recently gained increased attention as a means of deepening the understanding of the development of treatments for age-related diseases, as age-related changes serve as the fundamental commonality among these conditions. While chronological age (CA) is measured in years, BA can be measured in a wide variety of ways. In this thesis blood biomarkers correlated with CA were used as input to create BA estimates, with the algorithms PhenoAge, Klemera-Doubal method and Homeostatic Dysregulation. The serum biomarkers were selected by Pearson and Spearman correlation with CA separately per sex. The cohort AMORIS (Apolipoprotein-related MOrtality RISk) was used to calculate three different BA scores with the help of the BioAge package. To avoid collinearity, the residuals from these BA scores, which represent the deviation of BA from CA, were employed. The PhenoAge residuals were selected for further investigation due to their robustness. Association between BA residuals, particularly PhenoAge residuals, and Alzheimer’s disease and related dementias (ADRD) was assessed using Cox proportional hazard models. Adjustment was done for sex, education level and socioeconomic status. Stratification for two age groups, over 65 and under 65, as well as sex was done for two different models. The model concordance varied, overall, it was better for vascular dementia and worst for Alzheimer's disease. An increased hazard ratio was found especially for vascular dementia (PhenoAge HR=1.086, 95% CI=1.074 to 1.099), and to a lesser extent for other dementia types but not for Alzheimer's disease. Stratification by age and sex presented varied hazard ratios, suggesting different risk profiles among demographic groups. An increased risk for vascular dementia was especially noted in the age group under 65 and men. These differentiated risks, highlight the importance of BA markers in pinpointing elevated risks for dementia subtypes and affirm the value of incorporating BA into the assessment of ADRD for use in precision medicine.

Page generated in 0.044 seconds